Search results
Eluminex doses first patient in Phase I LOTUS trial for DME treatment
Clinical Trials Arena· 41 minutes agoChinese biotechnology company Eluminex Biosciences has dosed the first patient with its trispecific...
Nipah monoclonal antibody trials may begin in India in 2025
The Hindu· 3 days agoIf the Indian drug regulator greenlights it, a human clinical trial to test the safety and efficacy...
Mabwell’s 9MW2821 gains FDA fast track status for breast cancer
Pharmaceutical Technology· 1 day agoThe US Food and Drug Administration (FDA) has granted fast track designation to biopharmaceutical...
Nona Biosciences partners with Alaya.bio for CAR-T therapy
Pharmaceutical Technology· 23 hours agoNona's site-specific conjugation technology maintains the antibody's binding and function, improving...
Scientist decode a 125-year-old element capable of eliminating cancer cells
CNBC Awaaz· 2 hours agoUS scientists have unlocked the potential of a 125-year-old element that could combat cancer cells....
Enemies of Democracy
The Dispatch· 11 hours agoFrom the Boiling Frogs on The Dispatch The Donald Trump campaign rally site in Butler, Pennsylvania, on July 13, 2024, is empty and littered with debris...
J&J asserts its place in atopic dermatitis space with Yellow Jersey acquisition
Pharmaceutical Technology· 5 days agoThrough the all-cash purchase, J&J is set to gain ownership of NM26, a novel bispecific antibody...
US scientists decode 125-year-old element to boost cancer treatments
Daiji World· 20 hours agoNew Delhi, Jul 15 (IANS): US researchers have decoded an element that could destroy cancerous cells,...
Woman Who Received first-ever Combined Heart Pump And Pig Kidney Transplant Dies
Times Now· 6 days agoA 54-year-old grandmother - the first person to receive a mechanical heart pump along with a...
MSD closes $1.3bn EyeBio acquisition, plans pivotal trial for lead asset
Pharmaceutical Technology· 4 days agoEyeBio’s shareholders will receive approximately $0.50 per share, totalling $1.3bn. Following the...